What are the safety and efficacy outcomes of retatrutide in clinical trials?
Year: 2026
Type: article
Abstract: Retatrutide demonstrates strong efficacy in reducing HbA1c levels and body weight in clinical trials, though common gastrointestinal adverse effects require careful monitoring. Its robust weight loss outcomes may offer a valuable option for patients with type 2 diabetes and obesity.
Author: Tripdatabase
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7233758675
